A Study of CDX-0159 in Patients With Eosinophilic Esophagitis

Completed · Phase 2 · Has a placebo group

Conditions studied: Eosinophilic Esophagitis

In brief

The purpose of this study is to assess the efficacy and safety of barzolvolimab in adult Eosinophilic Esophagitis patients.

Key facts

Study ID
NCT05774184
Run by
Celldex Therapeutics
People needed
86
Starts
2023-06-01
Expected to finish
2026-01-23
Last updated by the study team
2026-05-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.